| 2.1 |
6.3 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 1.9 |
5.7 |
GO:2000412 |
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 1.8 |
1.8 |
GO:0098759 |
interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 1.7 |
1.7 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 1.7 |
5.1 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.6 |
3.2 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 1.4 |
2.9 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 1.4 |
4.2 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.4 |
5.4 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 1.3 |
5.3 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 1.3 |
3.8 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 1.1 |
5.6 |
GO:0038156 |
interleukin-3-mediated signaling pathway(GO:0038156) |
| 1.1 |
3.3 |
GO:0030920 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.1 |
3.3 |
GO:0010933 |
macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
| 1.1 |
6.5 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 1.0 |
4.1 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.0 |
3.0 |
GO:0009720 |
detection of hormone stimulus(GO:0009720) |
| 1.0 |
3.9 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.0 |
2.9 |
GO:0043465 |
fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.9 |
2.8 |
GO:1990922 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.9 |
3.7 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.9 |
6.4 |
GO:0010732 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.9 |
15.2 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.9 |
4.5 |
GO:0044855 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.9 |
1.8 |
GO:0071661 |
granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 0.9 |
6.2 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.9 |
2.6 |
GO:0002380 |
immunoglobulin secretion involved in immune response(GO:0002380) |
| 0.9 |
4.4 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.9 |
4.3 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.9 |
1.7 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.9 |
2.6 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.8 |
5.0 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.8 |
9.2 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.8 |
5.0 |
GO:0010868 |
negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 0.8 |
4.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.8 |
0.8 |
GO:1903004 |
regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 0.8 |
9.8 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.8 |
2.4 |
GO:0070377 |
negative regulation of ERK5 cascade(GO:0070377) |
| 0.8 |
2.4 |
GO:0060981 |
cell migration involved in coronary angiogenesis(GO:0060981) |
| 0.8 |
3.2 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.8 |
4.0 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.8 |
16.0 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.8 |
1.6 |
GO:0002277 |
myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.8 |
3.1 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.8 |
3.1 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.8 |
7.6 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.8 |
2.3 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.8 |
0.8 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.8 |
6.8 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.8 |
3.0 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.7 |
3.0 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.7 |
0.7 |
GO:0060928 |
atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.7 |
10.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.7 |
64.5 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.7 |
3.7 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.7 |
1.5 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.7 |
2.9 |
GO:0035625 |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.7 |
5.1 |
GO:0002774 |
Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.7 |
4.4 |
GO:1903238 |
positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 0.7 |
2.2 |
GO:1901383 |
negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 0.7 |
4.3 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.7 |
3.6 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.7 |
3.6 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.7 |
2.8 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.7 |
21.1 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.7 |
4.9 |
GO:0030421 |
defecation(GO:0030421) |
| 0.7 |
2.8 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.7 |
9.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.7 |
2.1 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.7 |
2.1 |
GO:1904772 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.7 |
3.5 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.7 |
2.7 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 0.7 |
3.4 |
GO:0072141 |
renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
| 0.7 |
2.0 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 0.7 |
2.7 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.7 |
6.1 |
GO:0014057 |
positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.7 |
5.4 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.7 |
0.7 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.7 |
2.0 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.6 |
3.2 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.6 |
3.9 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.6 |
1.3 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) |
| 0.6 |
3.2 |
GO:0002442 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.6 |
1.9 |
GO:0099553 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.6 |
2.5 |
GO:0052027 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.6 |
1.9 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.6 |
2.5 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.6 |
3.1 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.6 |
3.1 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.6 |
0.6 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.6 |
2.4 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.6 |
1.8 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.6 |
1.8 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.6 |
0.6 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.6 |
0.6 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 0.6 |
0.6 |
GO:0032615 |
interleukin-12 production(GO:0032615) |
| 0.6 |
4.1 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.6 |
3.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.6 |
1.7 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.6 |
2.9 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.6 |
2.9 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.6 |
2.9 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.6 |
2.8 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.6 |
4.5 |
GO:1903142 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.6 |
4.5 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.6 |
0.6 |
GO:0097017 |
renal protein absorption(GO:0097017) |
| 0.5 |
4.9 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.5 |
1.6 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 0.5 |
2.2 |
GO:0052416 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.5 |
1.6 |
GO:1901874 |
negative regulation of post-translational protein modification(GO:1901874) |
| 0.5 |
2.7 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.5 |
2.2 |
GO:0002913 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.5 |
1.1 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.5 |
8.5 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.5 |
1.6 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.5 |
2.1 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 0.5 |
3.2 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.5 |
1.1 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.5 |
1.6 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.5 |
1.6 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.5 |
5.2 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.5 |
1.5 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.5 |
1.5 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.5 |
2.0 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 |
2.5 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.5 |
4.6 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 |
3.0 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.5 |
3.0 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.5 |
2.0 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.5 |
2.5 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.5 |
2.5 |
GO:0036166 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.5 |
10.4 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.5 |
6.4 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.5 |
3.9 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.5 |
1.5 |
GO:0031064 |
negative regulation of histone deacetylation(GO:0031064) |
| 0.5 |
1.4 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.5 |
1.4 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.5 |
0.9 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.5 |
0.9 |
GO:0000967 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.5 |
0.5 |
GO:0060722 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.5 |
1.9 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.5 |
2.3 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.5 |
1.4 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.5 |
5.5 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.5 |
0.9 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.5 |
1.8 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.5 |
3.6 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.4 |
1.3 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.4 |
3.1 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 |
0.4 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.4 |
0.9 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.4 |
3.1 |
GO:0061364 |
apoptotic process involved in luteolysis(GO:0061364) |
| 0.4 |
1.8 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.4 |
3.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.4 |
1.3 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.4 |
1.8 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.4 |
8.6 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.4 |
6.9 |
GO:0001946 |
lymphangiogenesis(GO:0001946) |
| 0.4 |
1.3 |
GO:0002730 |
regulation of dendritic cell cytokine production(GO:0002730) |
| 0.4 |
0.8 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.4 |
10.6 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.4 |
0.4 |
GO:1904845 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.4 |
0.4 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.4 |
1.7 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.4 |
1.7 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.4 |
0.4 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.4 |
4.2 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.4 |
1.3 |
GO:2000793 |
cell proliferation involved in heart valve development(GO:2000793) |
| 0.4 |
0.8 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.4 |
1.7 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.4 |
1.7 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.4 |
2.9 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.4 |
2.5 |
GO:0072011 |
glomerular endothelium development(GO:0072011) |
| 0.4 |
4.5 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.4 |
1.6 |
GO:1902728 |
positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.4 |
4.5 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.4 |
1.2 |
GO:1903597 |
negative regulation of gap junction assembly(GO:1903597) |
| 0.4 |
1.2 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 0.4 |
1.2 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.4 |
3.6 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.4 |
1.6 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.4 |
1.6 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.4 |
2.0 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.4 |
7.2 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.4 |
1.6 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.4 |
3.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.4 |
1.9 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 |
2.3 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.4 |
1.5 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.4 |
57.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.4 |
1.2 |
GO:0048370 |
lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
| 0.4 |
2.3 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.4 |
1.2 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.4 |
1.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.4 |
2.3 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.4 |
3.1 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.4 |
1.9 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.4 |
1.1 |
GO:2000564 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.4 |
8.6 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.4 |
3.4 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.4 |
1.5 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.4 |
1.1 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.4 |
2.6 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.4 |
3.3 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.4 |
2.6 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.4 |
3.3 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.4 |
1.1 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.4 |
6.2 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.4 |
1.8 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.4 |
36.8 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.4 |
2.6 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.4 |
2.9 |
GO:1903140 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.4 |
1.8 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.4 |
1.1 |
GO:0036290 |
protein trans-autophosphorylation(GO:0036290) peptidyl-serine trans-autophosphorylation(GO:1990579) |
| 0.4 |
3.6 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.4 |
1.1 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.4 |
2.5 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.4 |
1.1 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.4 |
1.4 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.4 |
1.1 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.4 |
1.1 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.4 |
1.1 |
GO:0035378 |
carbon dioxide transmembrane transport(GO:0035378) |
| 0.4 |
2.8 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.4 |
1.1 |
GO:0000718 |
nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
| 0.4 |
0.7 |
GO:0002905 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.4 |
1.1 |
GO:0015734 |
taurine transport(GO:0015734) |
| 0.3 |
1.4 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.3 |
1.0 |
GO:0032490 |
detection of molecule of bacterial origin(GO:0032490) detection of bacterial lipoprotein(GO:0042494) |
| 0.3 |
1.0 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
1.0 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.3 |
1.0 |
GO:0048561 |
establishment of organ orientation(GO:0048561) |
| 0.3 |
1.4 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.3 |
2.1 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.3 |
6.9 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.3 |
36.8 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.3 |
0.7 |
GO:2000669 |
negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.3 |
3.8 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.3 |
1.0 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.3 |
2.4 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.3 |
5.0 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
6.0 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 |
2.7 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.3 |
0.7 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.3 |
5.3 |
GO:0046449 |
creatinine metabolic process(GO:0046449) |
| 0.3 |
2.3 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 |
2.3 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.3 |
1.3 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.3 |
3.3 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.3 |
1.0 |
GO:0035568 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.3 |
1.3 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.3 |
0.3 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.3 |
4.5 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.3 |
1.6 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.3 |
1.3 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 0.3 |
6.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.3 |
0.6 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.3 |
2.5 |
GO:0055011 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.3 |
1.9 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 |
2.5 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.3 |
0.9 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.3 |
1.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.3 |
1.3 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.3 |
1.6 |
GO:1902080 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.3 |
1.3 |
GO:0050822 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.3 |
1.6 |
GO:0032848 |
negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.3 |
0.9 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.3 |
1.2 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.3 |
0.6 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 |
2.8 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.3 |
0.3 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.3 |
1.5 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.3 |
1.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 |
1.2 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 |
5.5 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.3 |
3.1 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.3 |
1.2 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.3 |
1.5 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 |
0.6 |
GO:0044146 |
negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.3 |
11.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.3 |
2.4 |
GO:0090210 |
regulation of establishment of blood-brain barrier(GO:0090210) |
| 0.3 |
1.2 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.3 |
1.2 |
GO:0090472 |
viral protein processing(GO:0019082) negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.3 |
3.3 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.3 |
2.7 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.3 |
3.3 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.3 |
5.1 |
GO:1902285 |
semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.3 |
2.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.3 |
1.8 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.3 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
1.2 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.3 |
1.2 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.3 |
0.6 |
GO:0042091 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.3 |
0.9 |
GO:0034197 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.3 |
3.5 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.3 |
2.4 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.3 |
1.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 |
7.0 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
0.3 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.3 |
1.8 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.3 |
0.9 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.3 |
0.9 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.3 |
0.3 |
GO:0090274 |
regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.3 |
5.8 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.3 |
3.2 |
GO:0009972 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.3 |
0.3 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.3 |
0.6 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.3 |
2.3 |
GO:0045007 |
depurination(GO:0045007) |
| 0.3 |
0.6 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.3 |
7.7 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.3 |
1.7 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.3 |
0.3 |
GO:0071224 |
cellular response to peptidoglycan(GO:0071224) |
| 0.3 |
0.6 |
GO:0061027 |
umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 0.3 |
0.3 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.3 |
0.6 |
GO:2000644 |
regulation of receptor catabolic process(GO:2000644) |
| 0.3 |
0.6 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.3 |
2.0 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.3 |
0.6 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
| 0.3 |
1.7 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.3 |
5.3 |
GO:0045066 |
regulatory T cell differentiation(GO:0045066) |
| 0.3 |
0.6 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 |
1.1 |
GO:1903892 |
negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 0.3 |
1.9 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 |
2.5 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.3 |
0.3 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.3 |
1.1 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.3 |
0.8 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.3 |
1.1 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.3 |
0.8 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.3 |
1.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.3 |
1.1 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 |
1.1 |
GO:0032071 |
regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.3 |
0.5 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.3 |
0.3 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.3 |
0.8 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) |
| 0.3 |
0.3 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.3 |
3.7 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.3 |
1.3 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
0.8 |
GO:0035732 |
nitric oxide storage(GO:0035732) |
| 0.3 |
0.3 |
GO:0010748 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.3 |
0.8 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.3 |
6.9 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.3 |
1.6 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.3 |
0.5 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.3 |
1.8 |
GO:0050755 |
chemokine metabolic process(GO:0050755) |
| 0.3 |
5.8 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.3 |
4.5 |
GO:0014894 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 |
3.4 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.3 |
0.8 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.3 |
0.8 |
GO:0060921 |
sinoatrial node development(GO:0003163) cardiac pacemaker cell differentiation(GO:0060920) sinoatrial node cell differentiation(GO:0060921) cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
| 0.3 |
1.3 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.3 |
0.5 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.3 |
2.9 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 |
0.8 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.3 |
0.8 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.3 |
2.6 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.3 |
0.8 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.3 |
1.3 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.3 |
0.8 |
GO:2000798 |
amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.3 |
3.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.3 |
1.3 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.3 |
2.8 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.3 |
1.5 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.3 |
1.3 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 |
1.0 |
GO:0002483 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.3 |
3.5 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.3 |
1.0 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.3 |
0.3 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.3 |
0.5 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.3 |
1.0 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.2 |
5.2 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.2 |
0.5 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 0.2 |
3.7 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.2 |
1.0 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 |
0.2 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 0.2 |
1.5 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.2 |
1.5 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
6.1 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.2 |
0.5 |
GO:0002386 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.2 |
1.2 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.2 |
0.5 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.2 |
0.2 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.2 |
1.2 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 |
2.6 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.2 |
0.7 |
GO:0098736 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.2 |
4.8 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.2 |
0.7 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.2 |
8.3 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 |
2.8 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
1.6 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
1.6 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.2 |
0.9 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.2 |
2.6 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.2 |
0.2 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.2 |
0.2 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.2 |
0.2 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 0.2 |
0.7 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.2 |
1.1 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.2 |
1.6 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.2 |
0.7 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.2 |
0.9 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.2 |
0.9 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.2 |
1.3 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 |
1.3 |
GO:0014900 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.2 |
1.1 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.2 |
0.9 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.2 |
1.1 |
GO:0097647 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 |
1.3 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.7 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 |
0.4 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.2 |
0.7 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 |
1.5 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 |
1.8 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
0.4 |
GO:0033004 |
negative regulation of mast cell activation(GO:0033004) |
| 0.2 |
1.5 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 |
2.2 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.2 |
1.3 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.2 |
2.8 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.2 |
1.7 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.2 |
0.2 |
GO:1903433 |
regulation of constitutive secretory pathway(GO:1903433) |
| 0.2 |
1.7 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 |
1.9 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
1.3 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 |
0.4 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
3.9 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 |
0.4 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 |
0.6 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.2 |
0.2 |
GO:0060300 |
regulation of cytokine activity(GO:0060300) negative regulation of cytokine activity(GO:0060302) |
| 0.2 |
2.4 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
2.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
1.7 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.2 |
0.9 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.2 |
1.3 |
GO:0002325 |
natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 0.2 |
1.7 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
1.9 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.2 |
0.4 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.2 |
4.9 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.2 |
1.1 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.2 |
0.2 |
GO:0021784 |
postganglionic parasympathetic fiber development(GO:0021784) |
| 0.2 |
1.0 |
GO:0035513 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.2 |
1.0 |
GO:0030473 |
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.2 |
0.4 |
GO:0030812 |
negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.2 |
0.8 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.2 |
0.6 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 |
2.1 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.2 |
2.5 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.2 |
0.6 |
GO:0003218 |
cardiac left ventricle formation(GO:0003218) |
| 0.2 |
0.2 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.2 |
0.8 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
0.8 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.2 |
2.6 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.2 |
1.6 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.2 |
1.2 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 |
4.2 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 |
0.4 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.2 |
1.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.2 |
0.6 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.2 |
1.0 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.2 |
0.4 |
GO:0060528 |
positive regulation of translational initiation by iron(GO:0045994) secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 |
1.2 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
0.2 |
GO:0035963 |
cellular response to interleukin-13(GO:0035963) |
| 0.2 |
1.2 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
1.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
2.0 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.2 |
0.6 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
2.6 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
1.0 |
GO:0046504 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 |
0.6 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.2 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
1.2 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.2 |
0.4 |
GO:1903516 |
regulation of single strand break repair(GO:1903516) |
| 0.2 |
0.6 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.2 |
1.0 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.2 |
0.4 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 |
1.5 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.2 |
1.9 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.2 |
1.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
0.8 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.2 |
0.8 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.2 |
0.6 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 |
1.3 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.2 |
2.9 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.2 |
0.6 |
GO:0042700 |
luteinizing hormone signaling pathway(GO:0042700) |
| 0.2 |
1.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
2.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
1.3 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.2 |
0.6 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 |
1.5 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.2 |
0.8 |
GO:0035377 |
transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.2 |
1.5 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 |
1.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 |
2.1 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.2 |
0.7 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
0.6 |
GO:0071626 |
mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
| 0.2 |
1.1 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.2 |
1.7 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
0.6 |
GO:0022007 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 |
1.3 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.2 |
5.6 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.2 |
0.2 |
GO:0042223 |
interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.2 |
11.8 |
GO:0002260 |
lymphocyte homeostasis(GO:0002260) |
| 0.2 |
0.2 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
0.2 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.2 |
1.6 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.2 |
1.1 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.2 |
0.9 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 |
1.8 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 |
0.2 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.2 |
1.3 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.2 |
2.7 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.4 |
GO:2000439 |
positive regulation of monocyte extravasation(GO:2000439) |
| 0.2 |
1.1 |
GO:0070376 |
regulation of ERK5 cascade(GO:0070376) positive regulation of ERK5 cascade(GO:0070378) |
| 0.2 |
0.9 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
3.8 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.2 |
2.0 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 |
2.3 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
3.0 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.2 |
0.2 |
GO:1904938 |
dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
| 0.2 |
2.5 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
3.0 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.2 |
1.8 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 |
1.9 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 |
0.2 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
2.6 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 |
3.5 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
3.5 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.2 |
1.7 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
3.3 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 |
0.5 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.2 |
1.9 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.2 |
0.9 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.2 |
0.2 |
GO:0021650 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
| 0.2 |
1.2 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.2 |
1.4 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.2 |
1.4 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 0.2 |
0.5 |
GO:0002579 |
positive regulation of antigen processing and presentation(GO:0002579) |
| 0.2 |
1.9 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.2 |
1.5 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.2 |
0.3 |
GO:0075071 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 |
4.1 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.2 |
0.3 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
2.4 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.2 |
0.8 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.2 |
5.9 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.2 |
0.7 |
GO:0072047 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.2 |
3.5 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.2 |
0.7 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.2 |
0.8 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.2 |
0.5 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.2 |
0.3 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 0.2 |
1.0 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.2 |
1.2 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.2 |
2.5 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 |
1.2 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.2 |
0.5 |
GO:0071442 |
regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
3.0 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.2 |
3.6 |
GO:0072678 |
T cell migration(GO:0072678) |
| 0.2 |
26.0 |
GO:0002377 |
immunoglobulin production(GO:0002377) |
| 0.2 |
3.6 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
1.6 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.2 |
0.5 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.2 |
0.3 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.2 |
2.0 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
1.1 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.2 |
0.8 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.2 |
0.5 |
GO:0060581 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.2 |
0.5 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 |
1.1 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.2 |
0.6 |
GO:0061438 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
| 0.2 |
0.3 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.2 |
0.6 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.2 |
1.6 |
GO:0060211 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.2 |
1.8 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.2 |
1.6 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.2 |
0.5 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.2 |
1.6 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.2 |
0.5 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.2 |
0.9 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 |
0.5 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.2 |
0.8 |
GO:0060605 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.2 |
1.3 |
GO:0036022 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.2 |
0.2 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.2 |
0.5 |
GO:0097272 |
ammonia homeostasis(GO:0097272) |
| 0.2 |
1.1 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.2 |
0.3 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.2 |
10.4 |
GO:0050672 |
negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.2 |
0.5 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.2 |
1.4 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 |
1.1 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.2 |
0.6 |
GO:0061358 |
negative regulation of Wnt protein secretion(GO:0061358) |
| 0.2 |
4.8 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.2 |
0.8 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 |
0.3 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.2 |
0.5 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 |
0.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.2 |
0.3 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 |
0.3 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.2 |
0.3 |
GO:0014034 |
neural crest cell fate commitment(GO:0014034) |
| 0.2 |
1.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.2 |
0.8 |
GO:0039506 |
modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.2 |
1.4 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.2 |
0.5 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.2 |
1.5 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.2 |
2.6 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.2 |
0.5 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.2 |
1.4 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.2 |
0.9 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.2 |
1.4 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 |
1.3 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.1 |
1.0 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.6 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.1 |
GO:0032714 |
negative regulation of interleukin-5 production(GO:0032714) |
| 0.1 |
0.9 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.1 |
2.7 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.9 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 |
0.1 |
GO:0046833 |
positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.1 |
2.4 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.1 |
0.7 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
1.0 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
1.3 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
1.2 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.1 |
0.6 |
GO:0018201 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.1 |
4.2 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
3.6 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
0.4 |
GO:0061485 |
memory T cell proliferation(GO:0061485) |
| 0.1 |
3.2 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.1 |
1.6 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
0.4 |
GO:0044725 |
chromatin reprogramming in the zygote(GO:0044725) |
| 0.1 |
0.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.4 |
GO:0032431 |
activation of phospholipase A2 activity(GO:0032431) |
| 0.1 |
0.4 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.8 |
GO:0030581 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
2.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.1 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.1 |
1.6 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
1.0 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 |
1.5 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
1.0 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.6 |
GO:0090500 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 |
1.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
8.0 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 |
0.3 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.1 |
0.6 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 |
1.7 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
1.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.5 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
1.0 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
1.6 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.1 |
0.3 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.1 |
0.5 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.3 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
1.2 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
2.0 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
1.2 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.1 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 |
0.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.5 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 |
1.5 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
1.1 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.5 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.7 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.7 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 |
0.7 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.1 |
0.3 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.1 |
2.5 |
GO:2000303 |
regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.1 |
3.9 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.3 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.4 |
GO:0070316 |
regulation of G0 to G1 transition(GO:0070316) |
| 0.1 |
0.5 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 |
0.3 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.1 |
0.9 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.4 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 |
0.9 |
GO:0071651 |
positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.1 |
2.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.5 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.1 |
1.2 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 |
0.4 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.4 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.1 |
0.3 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.1 |
0.9 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.1 |
1.7 |
GO:1901739 |
negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) regulation of myoblast fusion(GO:1901739) negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 |
1.4 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 |
0.6 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 |
3.4 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.8 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
| 0.1 |
0.3 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.1 |
0.6 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
0.5 |
GO:0072672 |
neutrophil extravasation(GO:0072672) |
| 0.1 |
2.3 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.8 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
1.5 |
GO:0048313 |
Golgi inheritance(GO:0048313) |
| 0.1 |
0.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
1.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.4 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.1 |
1.1 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 |
0.5 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.1 |
0.7 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.6 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.1 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.4 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 |
0.4 |
GO:0035376 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 |
1.5 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.1 |
0.4 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.6 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
4.8 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.2 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
3.5 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.4 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.1 |
6.6 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 |
2.7 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 |
1.2 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
4.6 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
2.3 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 |
0.5 |
GO:0060969 |
negative regulation of gene silencing(GO:0060969) |
| 0.1 |
0.5 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 |
1.9 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
0.7 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
0.6 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.1 |
0.6 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
1.7 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.1 |
2.8 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.7 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.2 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
0.2 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
1.6 |
GO:0048505 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 |
0.1 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
1.6 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.1 |
0.4 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.1 |
0.7 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 |
0.5 |
GO:0060335 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 |
0.6 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 |
2.4 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
1.4 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.1 |
3.4 |
GO:1904776 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 |
0.5 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
1.5 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.1 |
5.3 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.1 |
0.7 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 |
2.0 |
GO:0035909 |
aorta morphogenesis(GO:0035909) |
| 0.1 |
0.8 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
2.6 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 |
1.8 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 |
2.6 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
0.1 |
GO:0003184 |
pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.1 |
0.4 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
0.6 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.1 |
1.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
2.1 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.2 |
GO:0048205 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
1.9 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 |
0.3 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.1 |
0.3 |
GO:0021873 |
forebrain neuroblast division(GO:0021873) |
| 0.1 |
1.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.1 |
0.3 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.4 |
GO:0035853 |
chromosome passenger complex localization to spindle midzone(GO:0035853) |
| 0.1 |
0.2 |
GO:2000678 |
negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.1 |
1.4 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
1.1 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
2.4 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.6 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.1 |
0.5 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.2 |
GO:2000360 |
negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 |
0.7 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.1 |
0.6 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
1.8 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
1.2 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.1 |
2.1 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.1 |
0.5 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
3.0 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.4 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 |
1.8 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.1 |
GO:0061550 |
cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) |
| 0.1 |
2.2 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
2.0 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.6 |
GO:0010166 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.1 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.1 |
0.4 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
0.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
0.5 |
GO:0045655 |
regulation of monocyte differentiation(GO:0045655) |
| 0.1 |
0.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
1.0 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.5 |
GO:0014004 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.3 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.9 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.1 |
12.1 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.1 |
0.5 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.1 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 |
0.9 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.1 |
7.6 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
0.6 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.1 |
0.7 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.1 |
2.8 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.5 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.1 |
1.6 |
GO:0043584 |
nose development(GO:0043584) |
| 0.1 |
0.9 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 |
0.2 |
GO:2000742 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.1 |
0.3 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
1.7 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
0.7 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.3 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
2.7 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
2.0 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
0.9 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.1 |
0.4 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.1 |
3.2 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.1 |
0.4 |
GO:0014038 |
regulation of Schwann cell differentiation(GO:0014038) |
| 0.1 |
0.2 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 |
1.8 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.9 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.9 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) |
| 0.1 |
0.1 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) |
| 0.1 |
1.5 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.1 |
0.6 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.1 |
0.3 |
GO:1900114 |
positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.1 |
0.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.8 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.1 |
2.0 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
| 0.1 |
0.2 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
| 0.1 |
2.0 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 |
0.2 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 |
0.7 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.1 |
0.3 |
GO:0001189 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 |
0.1 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.1 |
0.6 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.2 |
GO:0044026 |
DNA hypermethylation(GO:0044026) |
| 0.1 |
1.3 |
GO:0070862 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
2.0 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.6 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
1.2 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.5 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.1 |
1.3 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.1 |
0.2 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.1 |
1.6 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.1 |
0.2 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
0.8 |
GO:0050961 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
3.7 |
GO:0001704 |
formation of primary germ layer(GO:0001704) |
| 0.1 |
0.5 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
1.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.2 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.1 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 |
0.2 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
0.1 |
GO:2000848 |
positive regulation of corticosteroid hormone secretion(GO:2000848) |
| 0.1 |
0.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.8 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.6 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
0.3 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 |
1.3 |
GO:0043485 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 |
1.1 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 |
0.3 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.1 |
0.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.6 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
2.5 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
6.8 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
0.1 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.1 |
4.8 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
1.1 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
0.5 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.4 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
1.3 |
GO:0002042 |
cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.1 |
0.6 |
GO:0043537 |
negative regulation of blood vessel endothelial cell migration(GO:0043537) |
| 0.1 |
0.6 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.7 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
0.1 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.1 |
1.0 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.3 |
GO:0098957 |
anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.1 |
0.4 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.7 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
6.6 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 |
0.2 |
GO:0043970 |
histone H3-K9 acetylation(GO:0043970) |
| 0.1 |
0.2 |
GO:1901538 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
0.8 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 |
0.2 |
GO:0042090 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.1 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 |
1.6 |
GO:1901224 |
positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.1 |
0.5 |
GO:0097384 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular lipid biosynthetic process(GO:0097384) |
| 0.1 |
0.9 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.1 |
0.2 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.1 |
0.5 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.4 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 |
0.7 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.1 |
1.2 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.1 |
0.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
2.0 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.2 |
GO:0044793 |
negative regulation by host of viral process(GO:0044793) |
| 0.1 |
1.6 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.3 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 |
43.9 |
GO:0042119 |
neutrophil activation(GO:0042119) |
| 0.1 |
0.4 |
GO:0001507 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 |
0.4 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 |
0.4 |
GO:0072733 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 |
0.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
1.1 |
GO:0006921 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.1 |
0.4 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.1 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
0.1 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 |
0.1 |
GO:2000359 |
regulation of binding of sperm to zona pellucida(GO:2000359) |
| 0.1 |
0.1 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.1 |
0.9 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.1 |
0.3 |
GO:0045002 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
0.3 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.2 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.1 |
1.1 |
GO:0032802 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.1 |
0.2 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.1 |
0.2 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
0.1 |
GO:1904732 |
regulation of electron carrier activity(GO:1904732) |
| 0.1 |
0.1 |
GO:0003207 |
cardiac chamber formation(GO:0003207) |
| 0.1 |
0.2 |
GO:1903977 |
positive regulation of Schwann cell migration(GO:1900149) positive regulation of glial cell migration(GO:1903977) regulation of Schwann cell chemotaxis(GO:1904266) positive regulation of Schwann cell chemotaxis(GO:1904268) Schwann cell chemotaxis(GO:1990751) |
| 0.1 |
0.6 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.1 |
0.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.1 |
GO:0002525 |
acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.1 |
0.1 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
| 0.1 |
0.4 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
4.4 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
0.3 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
1.8 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
0.8 |
GO:0048048 |
embryonic eye morphogenesis(GO:0048048) |
| 0.1 |
3.4 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 |
0.5 |
GO:0034375 |
high-density lipoprotein particle remodeling(GO:0034375) |
| 0.1 |
0.3 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
1.1 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.2 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.6 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.3 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
0.2 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
0.3 |
GO:1903309 |
negative regulation of histone modification(GO:0031057) histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of chromatin modification(GO:1903309) |
| 0.1 |
0.5 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.2 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.1 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.1 |
0.2 |
GO:0009253 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 |
0.2 |
GO:1902594 |
viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.1 |
0.3 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.1 |
0.2 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 |
1.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
0.5 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.1 |
1.8 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
0.3 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.1 |
0.5 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.5 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.9 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.6 |
GO:0070231 |
T cell apoptotic process(GO:0070231) |
| 0.1 |
0.2 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.1 |
0.3 |
GO:0045634 |
regulation of melanocyte differentiation(GO:0045634) |
| 0.1 |
0.1 |
GO:0032954 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
0.3 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 |
2.6 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
0.7 |
GO:0032196 |
transposition(GO:0032196) |
| 0.1 |
0.6 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.9 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
5.5 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
4.5 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.2 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.2 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 |
1.7 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
| 0.1 |
0.1 |
GO:0002357 |
defense response to tumor cell(GO:0002357) |
| 0.1 |
0.2 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.1 |
0.2 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.1 |
0.1 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.2 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 |
0.2 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
0.1 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.1 |
0.8 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.1 |
0.1 |
GO:1904693 |
embryonic nail plate morphogenesis(GO:0035880) midbrain morphogenesis(GO:1904693) |
| 0.1 |
0.3 |
GO:1902961 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 |
0.4 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.4 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.1 |
2.7 |
GO:0060396 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
2.5 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.1 |
0.5 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
0.2 |
GO:0033129 |
positive regulation of histone phosphorylation(GO:0033129) |
| 0.1 |
0.3 |
GO:0043535 |
regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.1 |
1.7 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
1.7 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 |
0.6 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.2 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.1 |
1.4 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.1 |
0.7 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
1.7 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.5 |
GO:0090493 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 |
0.2 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.1 |
2.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.1 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.1 |
0.1 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.1 |
0.2 |
GO:1901073 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.1 |
1.0 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.4 |
GO:0030888 |
regulation of B cell proliferation(GO:0030888) |
| 0.1 |
0.4 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
0.3 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
| 0.1 |
0.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
1.8 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.3 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.3 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.1 |
0.3 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.1 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.1 |
GO:1904975 |
response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.1 |
0.3 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 |
0.2 |
GO:0090656 |
t-circle formation(GO:0090656) |
| 0.1 |
0.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.2 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.7 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.1 |
0.3 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
1.0 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.1 |
0.6 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 |
0.2 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 |
0.8 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.1 |
0.6 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.1 |
0.9 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
0.2 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.1 |
0.3 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
0.1 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.1 |
0.2 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 |
0.3 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.4 |
GO:2000674 |
regulation of type B pancreatic cell apoptotic process(GO:2000674) |
| 0.1 |
0.4 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
1.7 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.0 |
2.2 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
2.5 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 |
0.6 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.0 |
0.2 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
1.0 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.6 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 |
0.1 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.7 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.0 |
0.3 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.6 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.0 |
0.6 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.0 |
0.0 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
1.2 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.0 |
0.4 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.4 |
GO:0031076 |
embryonic camera-type eye development(GO:0031076) |
| 0.0 |
0.5 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.1 |
GO:0034505 |
tooth mineralization(GO:0034505) |
| 0.0 |
0.1 |
GO:0007549 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.2 |
GO:0033028 |
myeloid cell apoptotic process(GO:0033028) |
| 0.0 |
2.3 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.0 |
0.4 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.9 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.3 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.4 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.7 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.2 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 |
0.6 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.2 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.0 |
0.8 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.1 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.0 |
0.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.5 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.0 |
1.1 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 |
0.4 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 |
0.5 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.0 |
0.0 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.0 |
1.0 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.3 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.0 |
0.5 |
GO:0046427 |
positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.0 |
0.0 |
GO:0060571 |
morphogenesis of an epithelial fold(GO:0060571) |
| 0.0 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.0 |
0.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.0 |
1.6 |
GO:0045815 |
positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.0 |
0.2 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.0 |
0.8 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.4 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 |
0.4 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.3 |
GO:0031179 |
peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.0 |
0.6 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) |
| 0.0 |
0.2 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.4 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 |
0.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.0 |
0.1 |
GO:1905214 |
regulation of RNA binding(GO:1905214) |
| 0.0 |
1.9 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.0 |
0.5 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.0 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.0 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.2 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.5 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.3 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.1 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.0 |
0.4 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.1 |
GO:0006844 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.0 |
0.9 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.0 |
0.4 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.2 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.1 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 |
0.5 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.0 |
0.1 |
GO:2001021 |
negative regulation of response to DNA damage stimulus(GO:2001021) |
| 0.0 |
2.4 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 |
0.0 |
GO:0038170 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
0.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.1 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.0 |
0.3 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
0.1 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.2 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.3 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 |
0.1 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.0 |
0.1 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 |
1.3 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 |
0.2 |
GO:1901725 |
regulation of histone deacetylase activity(GO:1901725) |
| 0.0 |
0.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.3 |
GO:0042023 |
DNA endoreduplication(GO:0042023) |
| 0.0 |
0.9 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.2 |
GO:0051280 |
negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) |
| 0.0 |
2.3 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.2 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.2 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.0 |
0.3 |
GO:0010744 |
positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
| 0.0 |
0.2 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.0 |
0.2 |
GO:1901355 |
cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
| 0.0 |
0.1 |
GO:2000980 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.1 |
GO:0071962 |
mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.0 |
0.2 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
0.2 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.0 |
0.6 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
1.2 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.0 |
0.1 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.0 |
0.4 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
2.5 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.2 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.0 |
0.3 |
GO:0036003 |
positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
| 0.0 |
0.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
1.5 |
GO:1902850 |
microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 |
0.1 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.0 |
0.3 |
GO:0001755 |
neural crest cell migration(GO:0001755) |
| 0.0 |
2.0 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
5.3 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.2 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.0 |
0.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.1 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.0 |
0.4 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.2 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 0.0 |
0.6 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.3 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.0 |
0.4 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.1 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.0 |
0.0 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.0 |
0.1 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 |
0.1 |
GO:0072684 |
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.0 |
0.2 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
0.1 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.0 |
2.9 |
GO:0002250 |
adaptive immune response(GO:0002250) |
| 0.0 |
0.1 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.1 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.0 |
0.1 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.0 |
1.5 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.1 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.0 |
0.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
1.3 |
GO:1904892 |
regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
| 0.0 |
0.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.1 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.0 |
0.0 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.0 |
0.3 |
GO:0051931 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 |
0.1 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.7 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.1 |
GO:0002040 |
sprouting angiogenesis(GO:0002040) |
| 0.0 |
0.7 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.0 |
0.4 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.0 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.0 |
0.1 |
GO:0072676 |
lymphocyte migration(GO:0072676) |
| 0.0 |
0.2 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.0 |
0.1 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.0 |
0.1 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.1 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.0 |
0.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.0 |
0.1 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.5 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 |
3.4 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
0.2 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.1 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.0 |
0.1 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 |
0.1 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.0 |
0.5 |
GO:0042267 |
natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 |
0.4 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.0 |
0.1 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.1 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.0 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.2 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.3 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.0 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.0 |
1.0 |
GO:0000082 |
G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.0 |
0.0 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.0 |
0.1 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.0 |
0.1 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.0 |
0.1 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 |
0.1 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.1 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.4 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 |
0.0 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.0 |
0.5 |
GO:0070555 |
response to interleukin-1(GO:0070555) |
| 0.0 |
0.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.1 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.0 |
0.0 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.0 |
0.4 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
0.0 |
GO:1903259 |
exon-exon junction complex disassembly(GO:1903259) |
| 0.0 |
0.5 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 |
0.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.0 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.1 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.0 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.0 |
0.2 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.1 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.0 |
0.3 |
GO:0071427 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 |
0.0 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.1 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.1 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.0 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
